key: cord-0875472-dham4nnk authors: Allocca, Mariangela; Fiorino, Gionata; Furfaro, Federica; Gilardi, Daniela; Radice, Simona; D’Amico, Ferdinando; Zilli, Alessandra; Danese, Silvio title: Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic date: 2020-04-15 journal: Clin Gastroenterol Hepatol DOI: 10.1016/j.cgh.2020.04.028 sha: af00d014b1fc9522bd2565157f8bc0f78759f234 doc_id: 875472 cord_uid: dham4nnk nan Since February 20 th , 2020, the SARS-COV2 infection spread in Lombardy, and in the rest of the Italian regions, forcing our Government to impose national lockdown 1 . Hospitals have been forced to adapt and to restructure their units to cope with this urgent new critical situation 2 . Alternative solutions have been found to manage patients with inflammatory bowel disease (IBD), including remote monitoring, drug home delivery, limitations for infusion units, and patient education on preventive measures from infection 3 , in order to maintain high quality care 4 . Our IBD team at Humanitas Clinical and Research Center (Rozzano, Milan, Italy) includes 7 gastroenterologists, 3 IBD nurses, 6 trial-coordinators, and 10 biologists. More than 4000 patients (75% from outside Lombardy) are in active follow-up. Seven hundred patients are treated with biological therapy and 118 are enrolled in 25 clinical trials. Our weekly activity includes: five full day outpatient clinics, endoscopy, and bowel ultrasound; multidisciplinary team discussions with the patient and other specialists, two dedicated timeslots for patients with ileo-anal pouch every week, and dedicated timeslots on demand for patients discharged from the hospital for a severe flare or surgical resection. Finally, the helpline allows to manage about 80 contacts every day. As previously reported 3 , the restrictions imposed by the Government have forced to adapt our structure and processes to face the COVID-19 emergency. Aim of this study was to report the outcomes of the restructuring of our IBD referral Centre (Humanitas Clinical and Research Centre). Specifically, we assessed how many patients received the standards of care following restructuring of clinical operations. Importantly, we analyzed the number of patients who missed/postponeed monitoring visits and exams because of the IBD unit readjustment, based on the ECCO's recommended standards of care. 4 . Three clinicians (42%) and one (33%) nurse were assigned to the COVID-19 units, 4 trials coordinators (66%) and all biologists and lab technicians (100%) were allowed to work from home. The reduction of the IBD personnel was balanced by the closure of clinics and procedures for nonurgent patients. However, no patient was withdrawn from clinical trial after the randomization, while 8 screening procedures were canceled (4 patients were shifted to another therapy and 4 procedures were postponed) (Fig.1) . All urgent endoscopic and imaging procedures were performed (100%), whereas all elective procedures were canceled due to the local restriction rules. 5 At the beginning of the Italian outbreak, our helpline received 280 contacts (+350%) per day by email/telephone to ask information about dealing with the COVID-19 situation. Our patients were given all relevant information and were invited to find educational material on the national IBD society (IG-IBD) and the national Patients' Association (AMICI) websites, as well as on our hospital weekly newsletter. After the first week, the number of contacts returned to the usual number before the outbreak. We measured on average the same increase (about +350%) of contacts after every change in the restriction rules announced by the Prime Minister, mainly asking how to deal with travel restrictions, preventive measures, and drug delivery. This is the first report on the outcomes of restructuring of an IBD unit during the COVID-19 pandemic. Implementation of virtual clinics, drug home delivery, and IBD networking was able to maintain acceptable standards of care for our IBD patients. Whether the IBD unit restructuring achieves the same outcomes in other local and national contexts remains to be investigated. COVID-19 Italia: Monitoraggio della situazione